Asher Biotherapeutics

Developer of immunotherapies for the treatment of cancer and autoimmune diseases

placeSan Francisco, California, United States calendar_todayFounded 2019 groups48 employees language asherbio.com

Social engagement

Social engagement: 4.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include RA Capital Management, Third Rock Ventures, Wellington, Y Combinator.

Investor typeCountShare
Venture capital847%
Private equity16%
Bank & private debt16%
Other / undisclosed741%

Recent activity

29 May 2026
Event
ASCO26
Coming soon